Updated
Updated · MarketWatch · May 11Sun Pharmaceutical Shares Hit 52-Week High of 1,872.40 Rupees as Sensex Falls 1.70%
11 articles · Updated · MarketWatch · May 11
- Sun Pharmaceutical rose 1.36% to 1,872.40 rupees on Monday, setting a new 52-week high in a broadly weak Indian market.
- That move topped the stock's previous 52-week peak of 1,857.95 rupees, reached on May 6.
- The gain came even as the BSE Sensex dropped 1.70% to 76,015.28, showing relative resilience in the session.
- Among peers, Zydus Lifesciences climbed 1.80% and Shilpa Medicare jumped 4.38%, while Dr. Reddy's fell 1.08%.
- Trading volume was 77,151 shares, well below the 50-day average of 164,738, suggesting the record came on lighter-than-usual activity.
Sun Pharma's stock hit a record high on low volume. Is this a sign of true strength or a deceptive market bubble? Amid a market crash and global tensions, is India's pharma sector truly a safe haven for investors? Can Sun Pharma's $11.75B Organon acquisition succeed where many other pharma mega-mergers have failed?